Optimising Treatment In Early Parkinson‘s Disease
This activity features presentations on optimising treatment in early Parkinson’s Disease (PD), as part of a symposia held in honour of esteemed neurologist David Marsden, aimed at enhancing education in the movement disorders sphere.
In Australian general practice it is estimated that on average practices will have four patients with PD and a new case of PD every four years. This combined with vague, slow progressive signs and symptoms ‘make it one of the masquerades of general practice’ . Early diagnosis of PD is essential because if left untreated it can produce severe disability in ten to fifteen years.
GPs are ideally placed to coordinate lifetime holistic care in those diagnosed with PD, and if GPs and specialist care complement each other it will improve the outcomes for patients with PD. GPs are often the first practitioners to identify adverse medication effects and conversely, identify when anti-Parkinsons medications are becoming ineffective.
This session features leading movement disorders experts from Australia and overseas discussing treatment optimisation in early Parkinson’s Disease.
- Describe the importance of early diagnosis in Parkinson’s Disease (PD)
- List the major classes of medicines used for the management of PD
- Identify safety considerations with current treatments
- Presenter(s):Heinz Reichmann
- Host:Western Health
- Duration:26.18 min
- Activity ID:109951
- QI&CPD Points:1
- Provider:Lateral Connections